Transparency, trustworthiness and usefulness in pre-eclampsia randomised controlled trials in the last three decades

CONCLUSION: The reporting of non-significant p-values and effect sizes increased after mandatory trial registration in 2010, along with the transparency and trustworthiness of most trials. RCTs need to be more transparent, trustworthy, and useful to increase the value of …